My top 10 things to watch Thursday, Aug. 8 1. Amazing second quarter for Club name Eli Lilly . The drugmaker easily beat Wall Street estimates for earnings and revenue, driven by the strong performances of blockbuster diabetes treatment Mounjaro and weight-loss drug Zepbound. CEO David Ricks says it's only the bottom of the first inning for Mounjaro. In addition, a pill for obesity is in the works.
Dave Ricks, chair and chief executive officer of Eli Lilly and Company speaks to the Economic Club of New York in New York City, U.S., March 12, 2024.. The drugmaker easily beat Wall Street estimates for earnings and revenue, driven by the strong performances of blockbuster diabetes treatment Mounjaro and weight-loss drug Zepbound. CEO David Ricks says it's only the bottom of the first inning for Mounjaro. In addition, a pill for obesity is in the works.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: CNBC - 🏆 12. / 72 続きを読む »
ソース: CNBC - 🏆 12. / 72 続きを読む »
ソース: CNBC - 🏆 12. / 72 続きを読む »
ソース: CNBC - 🏆 12. / 72 続きを読む »
ソース: CNBC - 🏆 12. / 72 続きを読む »